All Circulars (26015)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE permits trading in 14,08,604 new equity shares of AvenuesAI Ltd. arising from conversion of partly paid shares to fully paid up, … | |||||||||||||||
BSE permits trading in 14,08,604 new equity shares of AvenuesAI Ltd. arising from conversion of partly paid shares to fully paid up, effective March 06, 2026.
| |||||||||||||||
BSE permits trading in 14,08,604 new equity shares of AvenuesAI Ltd. arising from conversion of partly paid shares to fully paid up, … | |||||||||||||||
BSE permits trading in 14,08,604 new equity shares of AvenuesAI Ltd. arising from conversion of partly paid shares to fully paid up, effective March 06, 2026.
| |||||||||||||||
BSE notifies listing and trading permission for 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective … | |||||||||||||||
BSE notifies listing and trading permission for 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.
| |||||||||||||||
BSE lists 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026. | |||||||||||||||
BSE lists 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis, effective March 6, 2026.
| |||||||||||||||
BSE notifies trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis are listed and permitted … | |||||||||||||||
BSE notifies trading members that 43,04,000 new equity shares of Dr Lalchandani Labs Limited issued on rights basis are listed and permitted to trade from March 6, 2026.
| |||||||||||||||
BSE lists 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED issued on rights basis, effective March 6, 2026. Shares are ranked … | |||||||||||||||
BSE lists 43,04,000 new equity shares of DR LALCHANDANI LABS LIMITED issued on rights basis, effective March 6, 2026. Shares are ranked pari-passu with existing equity shares.
| |||||||||||||||
BSE permits trading in 1946 new equity shares of Grasim Industries Ltd. (Scrip Code: 500300) effective March 06, 2026, issued pursuant to … | |||||||||||||||
BSE permits trading in 1946 new equity shares of Grasim Industries Ltd. (Scrip Code: 500300) effective March 06, 2026, issued pursuant to conversion of partly paid shares to fully paid up on rights basis.
| |||||||||||||||
BSE permits trading in 1946 new equity shares of Grasim Industries Ltd. pursuant to conversion of partly paid shares to fully paid up, … | |||||||||||||||
BSE permits trading in 1946 new equity shares of Grasim Industries Ltd. pursuant to conversion of partly paid shares to fully paid up, effective March 06, 2026.
| |||||||||||||||
BSE permits trading in 1,946 new equity shares of Grasim Industries Ltd. arising from conversion of partly paid shares to fully paid up on … | |||||||||||||||
BSE permits trading in 1,946 new equity shares of Grasim Industries Ltd. arising from conversion of partly paid shares to fully paid up on rights basis, effective March 06, 2026.
| |||||||||||||||
BSE lists 13,20,000 new equity shares of Hazoor Multi Projects Limited issued on a preferential basis to non-promoters at Rs. 30/- per … | |||||||||||||||
BSE lists 13,20,000 new equity shares of Hazoor Multi Projects Limited issued on a preferential basis to non-promoters at Rs. 30/- per share, effective March 6, 2026.
| |||||||||||||||